Overview
About Oryxion
Oryxion stands at the forefront as a full-spectrum Data CRO, delivering precision-driven services across Clinical Data Management, Data Visualization, Statistical Programming, Biostatistics, Medical Writing, and Regulatory Affairs. Founded by technically experienced professionals, Oryxion blends scientific rigor with operational efficiency to support clinical research at every stage.
With an AI-enabled analytics engine at its core, Oryxion ensures accurate, compliant, and streamlined data flow from first patient in to final submission. Our ecosystem integrates advanced tools for data capture, cleaning, and monitoring including partner-sourced EDC, ePRO, IWRS, eTMF and CTMS to reduce cycle times and minimize manual interventions.
Our statistical programmers operate within a validated, automated environment powered by licensed systems to deliver robust outputs for interim and final analyses. Biostatisticians at Oryxion support everything from protocol design to complex modelling and adaptive trial frameworks. Medical writers collaborate closely with data teams to ensure narratives and summaries are synchronized and submission-ready.
Through strategic collaborations with Digital Health platforms, we enhance patient-centric data collection and real-time monitoring. This results in richer datasets, greater data granularity, and stronger clinical insights. Our infrastructure is designed to support audit-readiness, scalability, and seamless integration across studies, sponsors, and regulatory authorities.
We specialize in complex trial designs, including Adaptive, Basket, Umbrella, Crossover, Dose-Finding, and Equivalence trials, and offer deep domain knowledge across a wide range of therapeutic areas. With a total of 75+ years of End-to-End Clinical Development experience, 120+ years of combined Subject Matter Expertise, our team has contributed to over 700+ Global Regulatory Submissions.
With an AI-enabled analytics engine at its core, Oryxion ensures accurate, compliant, and streamlined data flow from first patient in to final submission. Our ecosystem integrates advanced tools for data capture, cleaning, and monitoring including partner-sourced EDC, ePRO, IWRS, eTMF and CTMS to reduce cycle times and minimize manual interventions.
Our statistical programmers operate within a validated, automated environment powered by licensed systems to deliver robust outputs for interim and final analyses. Biostatisticians at Oryxion support everything from protocol design to complex modelling and adaptive trial frameworks. Medical writers collaborate closely with data teams to ensure narratives and summaries are synchronized and submission-ready.
Through strategic collaborations with Digital Health platforms, we enhance patient-centric data collection and real-time monitoring. This results in richer datasets, greater data granularity, and stronger clinical insights. Our infrastructure is designed to support audit-readiness, scalability, and seamless integration across studies, sponsors, and regulatory authorities.
We specialize in complex trial designs, including Adaptive, Basket, Umbrella, Crossover, Dose-Finding, and Equivalence trials, and offer deep domain knowledge across a wide range of therapeutic areas. With a total of 75+ years of End-to-End Clinical Development experience, 120+ years of combined Subject Matter Expertise, our team has contributed to over 700+ Global Regulatory Submissions.